Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks like clinical trial matching and appointment prep, has raised $22 million in Series B funding.
The round was led by Battery Ventures, with participation from returning backers Nexus Venture Partners, Lightspeed, Y Combinator, and others.
Originally reported by TechCrunch. Read the full story at the original source.
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyThe humble cactus is an icon of resiliency. ...
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storySometimes new species evade detection becaus...
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyAll configurations of the Mac Mini are on sa...
Gaming PlayStation Which NVIDIA GPU is closest to the PS5? The answer isn't so simple It's a bit like comparing ap...